154 related articles for article (PubMed ID: 12232531)
21. [C-reactive protein in cardiovascular risk evaluation].
Fabijanić D; Banić M; Kardum D
Lijec Vjesn; 2006; 128(5-6):167-74. PubMed ID: 16910418
[TBL] [Abstract][Full Text] [Related]
22. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community.
McDonald S; Maguire G; Duarte N; Wang XL; Hoy W
Clin Sci (Lond); 2004 Feb; 106(2):121-8. PubMed ID: 12956621
[TBL] [Abstract][Full Text] [Related]
23. [Inflammatory markers and cytokines in cardiovascular disease].
Ogiwara F; Takahashi M; Ikeda U
Rinsho Byori; 2004 Aug; 52(8):686-92. PubMed ID: 15478624
[TBL] [Abstract][Full Text] [Related]
24. Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk.
Hammett CJ; Prapavessis H; Baldi JC; Varo N; Schoenbeck U; Ameratunga R; French JK; White HD; Stewart RA
Am Heart J; 2006 Feb; 151(2):367.e7-367.e16. PubMed ID: 16442901
[TBL] [Abstract][Full Text] [Related]
25. The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
Catena C; Cavarape A; Dotto L; Colussi G; Novehllo M; De Marchi S; Sechi LA
Adv Clin Path; 2003 Jan; 7(1):3-11. PubMed ID: 19774732
[TBL] [Abstract][Full Text] [Related]
26. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
[TBL] [Abstract][Full Text] [Related]
27. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
Lim HS; Blann AD; Lip GY
Circulation; 2004 Jun; 109(21):2524-8. PubMed ID: 15136493
[TBL] [Abstract][Full Text] [Related]
28. Identifying the vulnerable patient with rupture-prone plaque.
Weintraub HS
Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
[TBL] [Abstract][Full Text] [Related]
29. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
[TBL] [Abstract][Full Text] [Related]
30. Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis - interrelation with traditional cardiovascular risk factors.
Schillinger M; Exner M; Mlekusch W; Amighi J; Sabeti S; Schlager O; Wagner O; Minar E
Thromb Haemost; 2004 Mar; 91(3):610-8. PubMed ID: 14983239
[TBL] [Abstract][Full Text] [Related]
31. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
de Ferranti SD; Rifai N
Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
[TBL] [Abstract][Full Text] [Related]
32. Association between inflammation and hemostatic markers in atherothrombotic stroke.
Reganon E; Vila V; Martínez-Sales V; Vaya A; Lago A; Alonso P; Aznar J
Thromb Res; 2003; 112(4):217-21. PubMed ID: 14987914
[TBL] [Abstract][Full Text] [Related]
33. [Fibrinogen: a "new" cardiovascular risk factor].
Ernst E
Wien Med Wochenschr; 1991; 141(17):375-82. PubMed ID: 1771915
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein: a novel marker of cardiovascular risk.
Shah SH; Newby LK
Cardiol Rev; 2003; 11(4):169-79. PubMed ID: 12852794
[TBL] [Abstract][Full Text] [Related]
35. Fibrinogen: a new major risk factor for cardiovascular disease. A review of the literature.
de la Serna G
J Fam Pract; 1994 Nov; 39(5):468-77. PubMed ID: 7964545
[TBL] [Abstract][Full Text] [Related]
36. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.
Maturana MA; Breda V; Lhullier F; Spritzer PM
Metabolism; 2008 Jul; 57(7):961-5. PubMed ID: 18555838
[TBL] [Abstract][Full Text] [Related]
37. Rationale, design, methods and baseline characteristics of the Asklepios Study.
Rietzschel ER; De Buyzere ML; Bekaert S; Segers P; De Bacquer D; Cooman L; Van Damme P; Cassiman P; Langlois M; van Oostveldt P; Verdonck P; De Backer G; Gillebert TC;
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):179-91. PubMed ID: 17446795
[TBL] [Abstract][Full Text] [Related]
38. Inflammation, the metabolic syndrome and cardiovascular risk.
Tracy RP
Int J Clin Pract Suppl; 2003 Mar; (134):10-7. PubMed ID: 12793593
[TBL] [Abstract][Full Text] [Related]
39. Lipoprotein-associated phospholipase A2: an independent predictor of cardiovascular risk and a novel target for immunomodulation therapy.
Khakpour H; Frishman WH
Cardiol Rev; 2009; 17(5):222-9. PubMed ID: 19690473
[TBL] [Abstract][Full Text] [Related]
40. Assessment of inflammatory markers and endothelial function.
Järvisalo MJ; Juonala M; Raitakari OT
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):547-52. PubMed ID: 16912549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
